Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36,052 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The efficacy and safety of keverprazan, a novel potassium-competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double-blind multicentre study.
Chen S, Liu D, Chen H, Liao A, Li F, Liu C, Li X, Li S, Zhang Y, Wang Y, Xia M, Guo Q, Miao X, Wen Z, Xu M, Yin H, Chen H, Chen M, Xiao Y. Chen S, et al. Among authors: liu c, liu d. Aliment Pharmacol Ther. 2022 Jun;55(12):1524-1533. doi: 10.1111/apt.16959. Epub 2022 May 3. Aliment Pharmacol Ther. 2022. PMID: 35505467 Clinical Trial.
Efficacy and safety of lubiprostone for the treatment of functional constipation in Chinese adult patients: A multicenter, randomized, double-blind, placebo-controlled trial.
Xiao YL, Dai N, He SX, Tian A, Liu S, Tian ZB, Wang XY, Li YQ, Hou XH, Fang XC, Wen ZL, Zeng WZ, Xu H, Sun MJ, Liu YL, Wu YD, Shen XZ, Liu XW, Liu L, Chen MH. Xiao YL, et al. J Dig Dis. 2021 Nov;22(11):622-629. doi: 10.1111/1751-2980.13058. J Dig Dis. 2021. PMID: 34633753 Clinical Trial.
36,052 results
You have reached the last available page of results. Please see the User Guide for more information.